Found 7 matching trials
The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients
PHASE1This study in patients with stable schizophrenia will investigate the effec...
Location
Multiple Locations
A Study of Solid Formulations of JNJ-39393406 in Healthy Male Participants
PHASE1The purpose of the study is to compare the pharmacokinetics (what a medicat...
Location
Multiple Locations
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants
PHASE1The purpose of the study is to evaluate the safety and tolerability of mult...
Location
Multiple Locations
Novel Smoking Cessation Drug for Schizophrenia
PHASE2The investigators will evaluate effects of a novel drug that improves nicot...
Location
Western Psychiatric Institute and Clinic and affilated sites
The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive
PHASE2To evaluate the effects of the nicotinic allosteric modulator JNJ-39393406 ...
Location
Clinical Psychiatric Hospital
A Pharmacokinetic Study to Characterize JNJ-39393406 in the Cerebrospinal Fluid of Healthy Volunteers
PHASE1The purpose of this study is to investigate the concentration of JNJ-393934...
Location
Multiple Locations
Test of Novel Drug for Smoking Cessation
PHASE2The study will assess a novel active drug vs. placebo on ability to reduce ...
Location
Univ of Pittsburgh Medical Center